Page last updated: 2024-10-28

ibudilast and Brain Neoplasms

ibudilast has been researched along with Brain Neoplasms in 2 studies

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alban, TJ1
Bayik, D1
Otvos, B1
Rabljenovic, A1
Leng, L1
Jia-Shiun, L1
Roversi, G1
Lauko, A1
Momin, AA1
Mohammadi, AM1
Peereboom, DM1
Ahluwalia, MS1
Matsuda, K2
Yun, K1
Bucala, R1
Vogelbaum, MA1
Lathia, JD1
Ha, W1
Sevim-Nalkiran, H1
Zaman, AM1
Khasraw, M1
Nowak, AK1
Chung, L1
Baxter, RC1
McDonald, KL1

Other Studies

2 other studies available for ibudilast and Brain Neoplasms

ArticleYear
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; Brain Neoplasms; Glioblastoma; Humans; Immunotherapy; Macrophage Migration-Inhibitory Facto

2020
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).
    Scientific reports, 2019, 02-27, Volume: 9, Issue:1

    Topics: Aged; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; DNA Modifi

2019